ASPC President's Page: Advancing and Refining Cardiovascular Disease Prevention

Correction: Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives.

Frontiers in pharmacology·2026

Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives.

Frontiers in pharmacology·2026

2025: The year in cardiovascular disease - the year of triglyceride lowering therapies. Can we effectively reduce triglyceride-related residual cardiovascular disease and pancreatitis risk?

Archives of medical science : AMS·2026

The prevalence of obesity and its relationship to cardiometabolic risk factors in the LIPIDOGRAM studies.

Kardiologia polska·2026

Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies.

Current cardiology reports·2026

Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP).

Progress in cardiovascular diseases·2025

Cardiovascular event rate modifies response to pharmacologic LDL-C lowering in primary prevention: implications of a systematic review and meta-analysis for clinical practice.

American journal of preventive cardiology·2026

The ABCs of cardiovascular disease prevention: communicating what we know in 2026.

American journal of preventive cardiology·2026

Impact of risk factor burden and vascular bed involvement on dementia risk in individuals with established cardiovascular disease.

American journal of preventive cardiology·2026

Associations of county-level school expenditure around time of birth and cardiovascular health in young adulthood.

American journal of preventive cardiology·2026

Associations of the PREVENT Score with coronary artery and thoracic aortic calcification among South Asian Americans.

American journal of preventive cardiology·2026

Differences of plaque burden measures on CCTA in younger men and women.

American journal of preventive cardiology·2026

Phage anti-defense genes targeting NAD+ metabolism and DNA replication are associated with a broad host range against Klebsiella pneumoniae.

Virulence·2026

Hepatitis B surface antigen clearance rate with pegylated interferon-α therapy in different chronic hepatitis B virus infection populations: A systematic review and meta-analysis.

Chinese medical journal·2026

Pre-Clinical Development of Two DNA Vaccines Encoding MrkA of Klebsiella pneumoniae: Effect of Plasmid Backbone on Immunogenicity and Protective Efficacy Against Sepsis.

Microbial biotechnology·2026

Pre-pandemic preventive healthcare engagement and all-cause excess mortality during COVID-19: a county-level ecological study in the United States.

Annals of epidemiology·2026

Acute Fulminant Demyelination after the COVID-19 Vaccine: A Case Report and Review of the Literature.

Case reports in neurology·2026

Repositioning Primary Health Care in Sierra Leone: From Geographic Access to Effective Coverage.

Annals of global health·2026

Related Experiment Videos

ASPC President's Page: Advancing and Refining Cardiovascular Disease Prevention

Related Concept Videos

Correction: Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives.

Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives.

2025: The year in cardiovascular disease - the year of triglyceride lowering therapies. Can we effectively reduce triglyceride-related residual cardiovascular disease and pancreatitis risk?

The prevalence of obesity and its relationship to cardiometabolic risk factors in the LIPIDOGRAM studies.

Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies.

Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP).

Cardiovascular event rate modifies response to pharmacologic LDL-C lowering in primary prevention: implications of a systematic review and meta-analysis for clinical practice.

The ABCs of cardiovascular disease prevention: communicating what we know in 2026.

Impact of risk factor burden and vascular bed involvement on dementia risk in individuals with established cardiovascular disease.

Associations of county-level school expenditure around time of birth and cardiovascular health in young adulthood.

Associations of the PREVENT Score with coronary artery and thoracic aortic calcification among South Asian Americans.

Differences of plaque burden measures on CCTA in younger men and women.

Phage anti-defense genes targeting NAD+ metabolism and DNA replication are associated with a broad host range against Klebsiella pneumoniae.

Hepatitis B surface antigen clearance rate with pegylated interferon-α therapy in different chronic hepatitis B virus infection populations: A systematic review and meta-analysis.

Pre-Clinical Development of Two DNA Vaccines Encoding MrkA of Klebsiella pneumoniae: Effect of Plasmid Backbone on Immunogenicity and Protective Efficacy Against Sepsis.

Pre-pandemic preventive healthcare engagement and all-cause excess mortality during COVID-19: a county-level ecological study in the United States.

Acute Fulminant Demyelination after the COVID-19 Vaccine: A Case Report and Review of the Literature.

Repositioning Primary Health Care in Sierra Leone: From Geographic Access to Effective Coverage.

Related Experiment Videos

ASPC President's Page: Advancing and Refining Cardiovascular Disease Prevention

Related Concept Videos

Related Articles